3Cordeiro M F.Human anti-transforming growth factor-beta2 antibody:a new glaucoma anti-scarring agent[J].Invest Ophthalmol Vis Sci,1999,40(10):2225-2234.
4Nakamura M.DNA interstrand crosslinking agents and hu-man ocular fibroblasts:differential sensitivity to mitomycin-C and cis-diaminedichloroplatinum (II)[J].Exp Eye Res,1994,59(1):53-62.
5Belyea D A.Late onset of sequential multifocal bleb leaks after glaucoma filtration surgery with 5-fluorauracil and mitomycin-C[J].Am J Ophthalmol,1997,124(1):40-45.
6Akpek E K.A randomized trial of low-dose,topical mitomy-cin C in the treatment of severe vernal keratoconjunctivitis[J].Ophthalmology,2000,107(2):263-269.
7Boush G A.Results of endonasal laser-assisted dacryocysto-rhinostomy[J].Ophthalmology,1994,101(5):955-959.
8Lam S.Mitomycin as adjunct therapy in correcting iatrog-enic punctual stenosis[J].Ophthalmic Surg,1993,24(2):123-124.
9Cordeiro M F.TGF-β1,-β2&-β3 in vitro:biphasic effects on Tenon's fibroblast contraction,proliferation & migration[J].Invest Ophthalmol Vis Sci,2000,41(3):756-763.
10Siriwardena D.Human anti-transfoming growth factor beta-2 monoclonal antibody -a new modulator of wound healing in trabeculectomy:a randomized placebo controlled clinical study[J].Ophthalmology,2002,109(3):427-431.
